tiprankstipranks
Arcus Biosciences price target lowered to $25 from $36 at Morgan Stanley
PremiumThe FlyArcus Biosciences price target lowered to $25 from $36 at Morgan Stanley
4d ago
Arcus Biosciences retains rights to casdatifan
Premium
The Fly
Arcus Biosciences retains rights to casdatifan
4d ago
Arcus Biosciences prices 13.6M shares at $11.00 in underwritten offering
Premium
The Fly
Arcus Biosciences prices 13.6M shares at $11.00 in underwritten offering
4d ago
Arcus says new data demonstrated ‘best-in-class potential’ for casdatifan
PremiumThe FlyArcus says new data demonstrated ‘best-in-class potential’ for casdatifan
5d ago
Arcus Biosciences to present new data from Casdatifan at  2025 ASCO
Premium
The Fly
Arcus Biosciences to present new data from Casdatifan at 2025 ASCO
12d ago
Arcus Biosciences Appoints New Board Director
Premium
Company Announcements
Arcus Biosciences Appoints New Board Director
15d ago
Arcus Biosciences Reports Q3 2024 Results
PremiumCompany AnnouncementsArcus Biosciences Reports Q3 2024 Results
4M ago
Arcus Biosciences reports Q3 EPS ($1.00), consensus ($1.06)
Premium
The Fly
Arcus Biosciences reports Q3 EPS ($1.00), consensus ($1.06)
4M ago
Arcus Biosciences announces results from Part 1 of ARC-10 trial
Premium
The Fly
Arcus Biosciences announces results from Part 1 of ARC-10 trial
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100